It’s important to consider that ICL is approved by the local health authority, which means it has been determined to be safe and effective. As with any procedure, there are risks to consider.
If you have any questions or concerns it's always best to speak with a certified ICL doctor.
The Visian ICL & TICL is designed for the correction of moderate to high near-sightedness (-0.5 to -20.0 dioptres (D)) and the reduction of near-sightedness in patients with up to -20 dioptres (D) of near-sightedness with less than or equal to 6.0 dioptres (D) of astigmatism.
It is indicated for patients who are 21 to 60 years of age.
In order to be sure that your surgeon will use an ICL with the most adequate power for your eye, your near-sightedness should be stable for at least a year before undergoing eye surgery.
ICL surgery has been documented to safely and effectively correct near-sightedness between -0.5 dioptres (D) to -20.0 dioptres (D) and partially correct near-sightedness up to -20 dioptres in eyes with up to 6.0(D) of astigmatism. With an anterior chamber depth (ACD) equal to or greater than 2.8 mm, as measured from the corneal endothelium to the anterior lens capsule.
If you have near-sightedness within these ranges, ICL surgery may improve your distance vision without eyeglasses or contact lenses.
ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before.
The ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct myopia such as contact lenses and eye glasses.
The ICL is not intended to correct any astigmatism you may have.
Implantation of the ICL is a surgical procedure, and as such, carries potentially serious risks.
The following represent potential complications/adverse events reported in conjunction with refractive surgery in general: conjunctival irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphema (blood in the eye), hypopyon (pus in the eye), eye infection, Visian ICL dislocation, macular edema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant.
Before considering ICL surgery you should have a complete eye examination and talk with your eye care professional about ICL surgery, especially the potential benefits, risks and complications.
You should discuss the time needed for healing after surgery.
1 Toda I, Asano-Kato N, Hori-Komai Y, Tsubota K. Laser-Assisted In Situ Keratomileusis for Patients With Dry Eye. Archives of Ophthalmology. 2002;120(8):1024-1028
2 Yu E, Leung A, Rao S, Lam DSC. Effect of laser in situ keratomileusis on tear stability. Ophthalmology, 2000; 107:2131-2135
3 ICL in Treatment of Myopia (ITM) Study Group. United States Food and Drug Administration clinical trial of the Implantable Collamer Lens (ICL) for moderate to high myopia. Ophthalmology. 2004;111:1683-1692